BC/WC Communication Tool for Cancer Decision Making in Older Adults
Trial Summary
What is the purpose of this trial?
This is a minimal risk, pilot cluster randomized controlled trial (CRT) to determine the feasibility and acceptability of training medical oncologists to use the Best Case/Worst Case-Geriatric Oncology (BC/WC-GeriOnc) communication tool in clinical practice with older adults with cancer.
Research Team
Rebecca Debouer, MD, MA
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for older adults aged 65 or above with any stage of solid tumor cancer, who are about to make a treatment decision. They must be able to understand and consent to the study, have adequate mental capacity, and speak English. Oncologists participating need to treat at least 10 such patients annually and commit to the study's duration.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Lead-In
Oncologists complete BC/WC-GeriOnc communication tool training and record decision-making discussions with patients
Cluster Randomized Trial (CRT)
Oncologists are randomized to intervention or control, with decision-making discussions recorded and questionnaires completed
Follow-up
Participants and caregivers complete follow-up questionnaires and interviews about decision-making and communication
Treatment Details
Interventions
- Best Case/Worst Case-Geriatric Oncology (BC/WC-GeriOnc) communication tool
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Mount Zion Health Fund
Collaborator